IndustryCompany release
Hydrofarm posts Q3 2026 sales drop to $14.5M and wipes out $109M term loan in October recapitalization
🇺🇸 Hydrofarm Holdings Group, Inc. (HYFM) · Mon 16 Nov 2026
Hydrofarm, a controlled environment agriculture supplier that is not a pharma company, reported Q3 2026 results (quarter ended Sept 30) on Nov 16, 2026. Net sales fell about 51% to $14.5M, while net loss narrowed to $7.8M and gross margin improved. In October the company recapitalized, converting its $109M Term Loan into preferred stock and warrants for lenders and raising about $8.3M in a registered direct offering and private placement, after selling Aurora Peat Products for $16M.
Company's press release (SEC filing): Hydrofarm Holdings Group, Inc. ↗
Brief written by VigiEye from the company's press release filed with the SEC. Claims are the company's own. AI-assisted; check the source before acting.
More Industry
All →
Gedeon Richter to acquire Mayne Pharma in AUD 604 million cash deal
Gedeon Richter · Mon 16 Nov 2026
Metagenomi puts hemophilia A editing candidate MGX-001 first in November 2026 deck
🇺🇸 Metagenomi Therapeutics, Inc. (MGX) · Mon 16 Nov 2026
Lifeloc Q3 revenue rises 12% as SpinDetect drug analyzer launch slips to Q4 2027
🇺🇸 Lifeloc Technologies, Inc (LCTC) · Mon 16 Nov 2026
Aytu BioPharma to be acquired by Rosemont for about $56M as EXXUA sales grow
🇺🇸 Aytu Biopharma, Inc (AYTU) · Mon 16 Nov 2026
Merck KGaA to acquire Rapid Micro Biosystems in $0.75-per-share cash tender offer
🇺🇸 Rapid Micro Biosystems, Inc. (RPID) · Mon 16 Nov 2026
Glass House Brands more than doubles Q3 revenue to $56.8M as net loss narrows
Glass House Brands Inc. (GLAS) · Mon 16 Nov 2026